Archive: Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute.
New FDA Commissioner, Same FDA Problem
The most beneficial regulations the new FDA commissioner can implement, by far, will be restrictions on the FDA itself.
Telemedicine Continues to Reach New Heights
Thankfully, telemedicine provides solutions for many who might otherwise suffer healthcare-access woes.
Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question
Peer-reviewed research and many case studies highlight weaknesses in the FDAs drug approval approach.
Is Right-to-Try Legislation a Bust? Time for a Second Opinion.
While right-to-try is currently underused, efforts to expand its role in helping those with terminal illnesses are underway.
Banning E-Cigarette Sales Will Do More Harm than Good
Efforts to ban vaping are extremely unlikely to succeed and may push consumers toward harmful alternatives.
How Government Prolonged the Lobotomy
While the lobotomy offers a cautionary tale of medicine gone astray, it should also provide a cautionary tale of the harmful consequences of state-assisted health policies.
New Study Finds FDA in Contempt of the U.S. Constitution
The vast majority of agency regulations were passed by “low-level officials and employees with no authority to issue rules.”
Worried About Big Pharma? Then Reduce the FDA’s Regulatory Power.
To compete for FDA attention, drug makers now needed a way to navigate new safety hurdles to have their products approved.
San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke
Government efforts to regulate away vices can also motivate more dangerous or unhealthy behaviors.